Westendorp RG - Search Results

1

Genetic influence on cytokine production and fatal meningococcal disease.

Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP. Westendorp RG, et al. Lancet. 1997 Jan 18;349(9046):170-3. doi: 10.1016/s0140-6736(96)06413-6. Lancet. 1997. PMID: 9111542

2

Release of tumor necrosis factor: an innate host characteristic that may contribute to the outcome of meningococcal disease.

Westendorp RG, Langermans JA, de Bel CE, Meinders AE, Vandenbroucke JP, van Furth R, van Dissel JT. Westendorp RG, et al. J Infect Dis. 1995 Apr;171(4):1057-60. doi: 10.1093/infdis/171.4.1057. J Infect Dis. 1995. PMID: 7706790

3

TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients.

Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, Breedveld FC, Verweij CL, van de Gaer L, Dams L, Crusius JB, García-Gonzalez A, van Oosten BW, Polman CH, Peña AS. Huizinga TW, et al. Among authors: westendorp rg. J Neuroimmunol. 1997 Feb;72(2):149-53. doi: 10.1016/s0165-5728(96)00182-8. J Neuroimmunol. 1997. PMID: 9042107

4

Genetic influence on cytokine production in meningococcal disease.

Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A. Westendorp RG, et al. Lancet. 1997 Jun 28;349(9069):1912-3. doi: 10.1016/s0140-6736(05)63910-4. Lancet. 1997. PMID: 9217780 No abstract available.

5

Are the effects of cholesterol lowering drugs always equal?

Vandenbroucke JP, Westendorp RG. Vandenbroucke JP, et al. Among authors: westendorp rg. Lancet. 1996 May 4;347(9010):1267-8. doi: 10.1016/s0140-6736(96)90790-4. Lancet. 1996. PMID: 8622487 No abstract available.

6

Determination of tumour necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation.

van der Linden MW, Huizinga TW, Stoeken DJ, Sturk A, Westendorp RG. van der Linden MW, et al. Among authors: westendorp rg. J Immunol Methods. 1998 Sep 1;218(1-2):63-71. doi: 10.1016/s0022-1759(98)00108-2. J Immunol Methods. 1998. PMID: 9819123

7

TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus.

Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, Verduyn W, Westendorp RG, de Vries RR, Breedveld FC, Verweij CL, Huizinga TW. Rood MJ, et al. Among authors: westendorp rg. Arthritis Rheum. 2000 Jan;43(1):129-34. doi: 10.1002/1529-0131(200001)43:1<129::AID-ANR16>3.0.CO;2-S. Arthritis Rheum. 2000. PMID: 10643708 Free article.

8

High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus.

van der Linden MW, Westendorp RG, Sturk A, Bergman W, Huizinga TW. van der Linden MW, et al. Among authors: westendorp rg. J Investig Med. 2000 Sep;48(5):327-34. J Investig Med. 2000. PMID: 10979237

9

Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosis.

de Jong BA, Schrijver HM, Huizinga TW, Bollen EL, Polman CH, Uitdehaag BM, Kersbergen MC, Sturk A, Westendorp RG. de Jong BA, et al. Among authors: westendorp rg. Ann Neurol. 2000 Oct;48(4):641-6. doi: 10.1002/1531-8249(200010)48:4<641::aid-ana11>3.3.co;2-q. Ann Neurol. 2000. PMID: 11026448

10

Are differences in interleukin 10 production associated with joint damage?

Huizinga TW, Keijsers V, Yanni G, Hall M, Ramage W, Lanchbury J, Pitzalis C, Drossaers-Bakker WK, Westendorp RG, Breedveld FC, Panayi G, Verweij CL. Huizinga TW, et al. Among authors: westendorp rg. Rheumatology (Oxford). 2000 Nov;39(11):1180-8. doi: 10.1093/rheumatology/39.11.1180. Rheumatology (Oxford). 2000. PMID: 11085795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

715 results

Search Page